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The continuation of our phytochemical survey of Lobaria pulmonaria (L.) Hoffm. 
(Lobariaceae), has led to the isolation and identification of a new lichen depsidone (1) 
characterised by the normal analytical and spectroscopic techniques. Unlike previously 
isolated depsidone (2) from the same species, the compound 1 has not showed activity in 
the acetylcholinesterase inhibition test on Thin-layer chromatography plate. 
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Lichens are by definition symbiotic organisms, usually composed of a fungal partner, the 
mycobiont, and one or more photosynthetic partners, the photobiont, which is most often either a 
green alga or cyanobacterium. The majority of organic compounds found in lichens are secondary 
metabolites of the fungal component, which are deposited on the surface of the hyphae rather than 
within the cells. These products are usually insoluble in water and can be only extracted with 
organic solvents. Of the acetyl-polymalonyl derived compounds, aromatic products are especially 
well represented, the most characteristic being depsides, depsidones, dibenzofurans, usnic acids 
and depsones. Other aromatic compounds of acetate-polymalonate origin, such as the chromanes, 
xanthones, and antraquinones are often identical or analogous to products of non-lichen forming 
fungi or higher plants [1].  
Lobaria pulmonaria (L.) Hoffm. (Ascomycotina, Peltigerales, Lobariaceae) is a foliose 
lichen with broad lobes and a greenish, reticulate upper surface with deep hollows [2]. The genus 
Lobaria is represented by a variety species, in which L. pulmonaria has been extensively studied 
and ß-Orcinol depsidones were found to be main constituents [3].  
As part of our ongoing project on natural products of lower marine and terrestrial 






1H- and 13C-NMR spectra were recorded at the NMR Service of the Institute for 
Biomolecular Chemistry of National Council Research of Italy (CNR-ICB) on a Bruker Avance-
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400 spectrometer operating 400 and 100 MHz, respectively, using an inverse probe fitted with a 
gradient along the Z-axis, in CDCl3, using the solvent signal as an internal standard. Thin-layer 
chromatography was carried out on pre-coated silica gel 60 F254 (0.25 mm, Merck, Darmstadt, 
Germany). LRMS and HRMS were recorded on a JEOL JMS D-300 and an AEI MS-50, 
respectively.  
 
2.2. Plant material 
 
The lichen Lobaria pulmonaria (L.) Hoffm. (Lobariaceae) was collected from Fagus 
sylvatica on the mountain Zelengora (Bosnia and Herzegovina) in July 2009. Voucher specimen 
has been deposited in the Herbarium of the Institute of Botany, University of Belgrade, Serbia 
(BEOU 5997). 
 
2.3. Extraction and isolation 
 
Before extraction the lichen was carefully inspected for contaminants. Air-dried parts of L. 
pulmonaria (70 g) were ground and extracted three times with CHCl3, CHCl3-MeOH 1:1, MeOH, 
and MeOH-H2O 1:1, respectively, (500 mL each) at room temperature, for up to 1 day each, with 
the extractives pooled and then evaporated in vacuo. The dried CHCl3-MeOH (1:1) extract (5.81 
g) was dissolved in H2O (50 mL) and partioned sequentially with CHCl3 (3 × 50 mL) and n-BuOH 
(3 × 50 mL). The crude insoluble colored residue (0.46 g), obtained after the partition, was 
classified as fraction rich in epsilons, by means of its spectroscopic data and typical 
chromatographic profile. In order to further characterise the residue, it was chromatographed on 
Sephadex LH-20 column (20 mg) and eluted with the system of methylene chloride/methanol 1:1 
to yield the fraction with a new depsidone (5 mg, 0.0071% of dry weight). 
 
New depsidone 1 (Figure 1): 1H NMR (DMSO-d6, 400 MHz) δ 10.44 (1H, s, H-9), 10.24 (1H, s, 
H-8’), 10.24  (1H, s, H-7’), 7.10 (1H, s, H-5), 3.92 (3H, s, 0CH3-4), 2.50 (3H, s, H-8), 2.19 (3H, s, 
H-9’); 13C NMR (DMSO-d6, 100 MHz) δ 186.7 (CHO, C-9), 170.6 (COOH, C-8’), 170.6 (COOH, 
C-7’), 163.2 (C, C-4), 163.2 (COO, C-7), 162.4 (C, C-2), 160.9 (C, C-2’), 147.9 (C, C-4’), 144.8 
(C, C-6), 137.4 (C, C-6’), 136.2 (C, C-5’), 120.5 (C, C-3’), 114.4 (C, C-3), 114.4 (C, C-1’), 113.1 
(C, C-1), 112.8 (CH, C-5), 56.8 (C, 0CH3-4), 21.6 (CH3, C-8), 9.6 (CH3, C-9’). ESIMS m/z 403 
[M+H]+ (calcd for C19H15O10 403.3096). 
 
2.4. Biological Assay 
 
Acetylcholinesterase inhibition test was performed dissolving the sample in MeOH at a 
concentration of 1 mg/mL. From this main solution was performed a serial dilution in order to 
obtain lower concentration of the sample (0.1; 0.01; 0.001 mg/mL), and 10 µL of each solution 
was applied to TLC plates to test 10, 1, 0.1, and 0.01 µg of the sample to detect the minimum 
concentration that inhibited AChE. Galantamine was used as positive control. The assay was 
carried out as described Marston, Kissling, & Hostettmann [6]. It is a simple and rapid 
bioautographic enzyme assay. The test relies on the cleavage by acetylcholinesterase of                 
1-naphthyl acetate to form 1-naphthol, which in turn reacts with Fast Blue B salt to give a purple-
coloured diazonium dye. Briefly, a stock solution of acetylcholinesterase (1000 U in 150 mL of 
Tris-hydrochloric acid buffer pH 7.8) was obtained, which was stabilised adding bovine serum 
albumin (150 mg). A 10 µL aliquot of each solution of the sample was applied to the TLC plates, 
dried to remove the solvent, and then sprayed with enzyme stock solution. For incubation of the 
enzyme, the plate was kept at 37 C for 20 min in a humid atmosphere. For the detection of the 
enzyme, solutions of 1-naphthyl acetate (250 mg in 100 mL of EtOH) and of Fast Blue B salt (400 
mg in 160 mL of distilled H2O) were mixed and sprayed onto the plate. Acetylcholinesterase 






3. Results and discussion 
 
High-resolution mass spectrometry established the molecular formula of a new lichen 
depsidone 1 (C19H14O10, Figure 1). The structure followed from 1-D and 2-D NMR spectra. The 
1H-NMR spectrum showed three three-proton singlets between δ 2.0 and 4.0, one-proton singlet 
between   δ 7.0 and 10.0, carboxylic protons at δ 10.24 and an aldehyde proton at δ 10.44; C-
carboxylic resonances were specific signals of the identified depsidone molecule. The 13C-NMR 
and DEPT spectra exhibited 19 carbon signals. A combination of 2-D NMR experiments (COSY, 




Fig. 1. A new lichen depsidone  
 
 
The AChE inhibition test [6,7] showed no activity for the compound 1. In comparison, the 
alkaloid galantamine used clinically for the treatment of Alzheimer’s disease [8] inhibited the 
enzyme at 0.01 µg, while a new depsidone 2 isolated from the same lichen in the form of its 
diacetate derivative  (C21H18O9, Figure 2) was active at 1 µg [9]. According to our best knowledge, 
it is the only identified depsidone with acetylcholinesterase inhibitory activity till date. On the 
other hand, AChE inhibitors are still considered the best drugs currently available for the 
management of Alzheimer's disease [10]. Because most inhibitors of AChE are alkaloids that often 
possess several side effects, it is important to search for new AChE inhibitors not belonging to this 









4. Conclusion  
 
Our results indicate the significance of covalent modification (acetylation) of depsidone 
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